Patents
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
08/2009
08/11/2009US7572914 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease
08/11/2009US7572820 Chemical compounds
08/11/2009US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
08/11/2009US7572790 Biphenyl carboxylic amide p38 kinase inhibitors
08/11/2009CA2362385C Heterodiazinon compound
08/05/2009EP2083816A2 Heterocyclic amide compounds useful as kinase inhibitors
08/05/2009EP1805144A4 Heterocyclical chromophore architectures
08/05/2009CN100522952C Insecticidal phthalamide derivatives
08/04/2009US7569724 Antiproliferative agnets; anticancer agents; skin disorders
07/2009
07/29/2009EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
07/29/2009EP2081916A1 Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties
07/29/2009CN101495465A 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands
07/28/2009US7566803 Vitamin D receptor modulators
07/23/2009WO2009067663A8 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
07/23/2009US20090186909 Oxadiazolidinedione Compound
07/22/2009CN100516119C Electroluminescent metallo-supramolecules with terpyridine-based groups
07/21/2009US7563822 active ingredient a 5-amidino-2-hydroxybenzenesulfonamide derivative or a pharmaceutical acceptable salt thereof; excellent inhibitory effect on mesangial cell proliferation and decreasing effect on urine protein excretion
07/15/2009EP1863774A4 Heterocyclical chromophore architectures with novel electronic acceptor systems
07/09/2009WO2009086277A1 Tetrasubstituted benzenes
07/09/2009WO2009084970A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
07/09/2009CA2710743A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
07/09/2009CA2710477A1 Tetrasubstituted benzenes
07/08/2009EP2076501A2 Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
07/08/2009EP1879573A4 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
07/08/2009CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase
07/07/2009US7557136 Pyrrolidine derivatives as oxytocin antagonists
07/02/2009WO2009082347A1 Bis- (sulf onylamino) derivatives for use in therapy
07/02/2009WO2009081891A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
07/02/2009WO2009080797A1 Romp-polymerizable electron transport materials based on a bis-oxadiazole moiety
07/02/2009WO2009080725A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
07/02/2009US20090170911 Novel azole compound
07/02/2009US20090170907 Chemical Compounds
07/02/2009US20090170824 Diarylsulfones as 5-HT2A Antagonists
07/02/2009CA2710130A1 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p)
07/02/2009CA2709510A1 Bis-(sulfonylamino) derivatives for use in therapy
07/02/2009CA2708447A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
07/01/2009EP1613610B1 Benzo 1,2,5 oxadiazoles and benzo 1,2,5 thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers
07/01/2009CN101472905A Substituted 5- phenylamino- 1, 3, 4-oxadiaz0l-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase
06/2009
06/30/2009US7553973 Pharmaceutical compounds
06/30/2009US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma
06/25/2009WO2009079597A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
06/25/2009WO2009079593A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
06/25/2009WO2009049961A3 New no-donor aspirin derivatives
06/25/2009US20090163549 Pharmaceutical Composition Comprising an Amide Derivative
06/25/2009US20090163485 Heteroaryl derivatives as orexin receptor antagonists
06/24/2009CN101466690A Crystalline form of (trans-4-[([5-[(3,4-difluorophenyl)amino]-1,3,4-oxadiazol-2-yl]carbonyl)amino]phenyl]cyclohexyl)acetic acid
06/24/2009CN101466689A Compounds for the inhibition of DGAT1 activity
06/23/2009US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases
06/18/2009WO2009075080A1 Fluoroalkylsulfide derivative and pest control agent
06/18/2009WO2009074733A2 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same
06/18/2009WO2009054923A3 Synthesis and crystalline forms of cb-1 antagonist/inverse agonist
06/17/2009EP2069318A1 Phenyl derivatives and their use as immunomodulators
06/17/2009EP2068871A1 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression
06/17/2009EP1789410B1 Methylene dipiperidine derivatives
06/17/2009CN101460470A 1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors
06/11/2009WO2009071577A1 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators
06/11/2009WO2009071519A1 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators
06/11/2009WO2009051718A3 Calcium receptor modulating agents
06/11/2009US20090149514 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/11/2009US20090149474 tert-butyl 4-[(4-chlorobenzoyl)amino]-2-(dimethylamino)-1-phenyl-1H-imidazole-5-carboxylate, used for the treatment of gastrointestinal disorders such as gastroesophageal reflux, irritable bowel syndrome, dyspepsia, diarrhea and for the inhibition of transient lower esophageal sphincter relaxations
06/11/2009US20090149425 Malononitrile compound as pesticides
06/10/2009EP0975710B2 Polymer electroluminescent device
06/04/2009WO2009067797A1 Cysteine protease inhibitors for the treatment of parasitic diseases
06/04/2009CA2706746A1 Cysteine protease inhibitors for the treatment of parasitic diseases
06/02/2009US7541372 Cyclopropylmethyl-{3-methoxy-4-[5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-phenyl}-amine; -{3-Methoxy-4-[5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-phenyl}-thiomorpholine; useful for the treatment of cognitive disorders like Alzheimer's disease
05/2009
05/28/2009WO2009067663A1 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
05/28/2009US20090137816 Process for the manufacture of diaminofurazan
05/28/2009US20090137642 2-Acylaminothiazole Derivatives
05/26/2009CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists
05/21/2009US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease
05/20/2009EP2059513A1 Processes for the preparation of 1,2,4-oxadiazole benzoic acids
05/20/2009CN100488963C New thiobizole formanide derivative and its synthesis process and bioactivity
05/20/2009CN100488955C New compound with activity of inducing secondary metabolism of Hypericum plant
05/19/2009US7534371 Composition R; having a rectangular plate-like shape, exhibits a liquid crystal phase having a positive birefringence; anda liquid crystalline composition D which exhibits a liquid crystal phase having a negative birefringence
05/19/2009CA2211381C Compounds with growth hormone releasing properties
05/19/2009CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
05/14/2009WO2009060278A1 Cyclobutyl carboxylic acid derivatives
05/14/2009US20090124669 Structural Analogues of Avenanthramides, Their Use in Compositions Useful in the Treatment of Dermatological Disorders
05/14/2009CA2703987A1 Cyclobutyl carboxylic acid derivatives
05/13/2009EP2057117A2 Compounds for treating proliferative disorders
05/13/2009EP1565429B1 Diaryl ureido derivatives and their medical use
05/13/2009EP1549624B1 Inhibitors of fatty acid amide hydrolase
05/07/2009WO2009058552A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
05/07/2009CA2704360A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
05/07/2009CA2703909A1 P2x3, receptor antagonists for treatment of pain
05/06/2009EP2054383A2 Novel compounds as antagonists or inverse agonists at opioid receptors
05/06/2009EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/06/2009CN101426775A Oxadiazolidinedione compound
05/06/2009CN101423502A 1-heterocycle-5-phenyl-2amylene-1-ones compounds as well as preparation method and application thereof
05/06/2009CN101423501A Heterocycle-containing 5-phenyl-2,4-pentadienyl-1-ones compounds as well as preparation method and application thereof
05/05/2009US7528137 Compounds, compositions, and methods
05/05/2009CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
04/2009
04/30/2009WO2009054923A2 Synthesis and crystalline forms of cb-1 antagonist/inverse agonist
04/30/2009WO2009054423A1 Oxadiazolidinedione compound
04/30/2009US20090111858 Novel Alpha-(N-Sulfonamido)Acetamide Compound as an Inhibitor of Beta Amyloid Peptide Production
04/30/2009US20090111857 1,2,4-triazole ether derivatives as modulators of mglur5
04/30/2009US20090111195 Chemical reagents and methods for detection and quantification of proteins in complex mixtures
04/30/2009US20090106915 Coloring hair non-oxidatively with pyridine dyes complexed with iron (II) ormanganese; 2-(Methyl-[2,2';6'2'']terpyridine-4'yl-amino)-ethanol ligand;no additional dye precursor needed, nor a pretreatment or a swelling agents;simplification
04/30/2009CA2703793A1 Oxadiazolidinedione compound
04/30/2009CA2703465A1 Synthesis and crystalline forms of cb-1 antagonist/inverse agonist
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 72